Your browser doesn't support javascript.
loading
Impact of prior treatment exposure on response to antidepressant treatment in late life.
Tew, James D; Mulsant, Benoit H; Houck, Patricia R; Lenze, Eric J; Whyte, Ellen M; Miller, Mark D; Stack, Jacqueline A; Bensasi, Salem; Reynolds, Charles F.
Afiliação
  • Tew JD; Advanced Center for Interventions and Services Research in Late-Life Mood Disorders, Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Am J Geriatr Psychiatry ; 14(11): 957-65, 2006 Nov.
Article em En | MEDLINE | ID: mdl-17068318
ABSTRACT

OBJECTIVE:

The objective of this study was to describe the correlates of prior antidepressant exposure and its association with response to protocolized treatment in older patients with major depression.

METHODS:

Based on their prior antidepressant treatment exposure, 193 elderly patients with a major depressive episode were divided into three groups those with no prior treatment for their current episode (not treated [TN]), those with antidepressant trials of inadequate dose or duration ("treatment-inadequate" [TI]), and those with at least one adequate trial but persisting depression ("treatment-resistant" [TR]). All patients then received protocolized treatment with interpersonal psychotherapy (IPT) and paroxetine plus pharmacologic augmentation if needed. The demographic, clinical, and outcome information were compared among these three groups.

RESULTS:

Approximately one-third of the patients referred to the study had been adequately treated (TR), one-third had been inadequately treated (TI), and one-third were not treated for the current episode (TN). Treatment completion rates and reasons for dropping out did not differ statistically among TR, TI, and TN patients. TR patients took longer to respond (13.0 weeks) than either TI or TN patients (7.6 and 8.0 weeks, respectively). TR and TI patients had lower response rates (67% and 71%) than TN patients (86%).

CONCLUSIONS:

Prior treatment exposure is an important correlate of course and outcome in late-life depression. Most TR and TI patients eventually respond, but TR patients may require more intensive and longer courses of treatment than TI and TN patients.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paroxetina / Antidepressivos de Segunda Geração / Transtorno Depressivo Maior Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Am J Geriatr Psychiatry Assunto da revista: GERIATRIA / PSIQUIATRIA Ano de publicação: 2006 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paroxetina / Antidepressivos de Segunda Geração / Transtorno Depressivo Maior Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Am J Geriatr Psychiatry Assunto da revista: GERIATRIA / PSIQUIATRIA Ano de publicação: 2006 Tipo de documento: Article País de afiliação: Estados Unidos